Literature DB >> 6677264

Immune profile alterations in thalassaemic patients.

L Quintiliani, A Mastromonaco, E Giuliani, A Buzzonetti, P Sisti, M Guglielmetti, P Iudicone, E Greca, A M Damiano, A M Ciancamerla.   

Abstract

Aspects of the humoral and cellular immune response have been studied in polytransfused patients with beta-thalassaemia major. Serum immunoglobulins (G, A, M) levels were significantly higher than in controls; reduced C4 serum level and high incidence of circulating immune complexes and anti-nuclear autoantibodies were found in the majority of patients. Marked increases were also observed in absolute and relative numbers of lymphocytes and their subpopulations. Such results suggested that the allogenic stimulation, by frequent transfusion, is the mainly responsible of the immunological alterations observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6677264

Source DB:  PubMed          Journal:  Boll Ist Sieroter Milan        ISSN: 0021-2547


  3 in total

1.  Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Authors:  Brigitta Buttari; Elisabetta Profumo; Patrizia Caprari; Sara Massimi; Francesco Sorrentino; Laura Maffei; Marco Gabbianelli; Rachele Riganò
Journal:  Ann Hematol       Date:  2020-08-15       Impact factor: 3.673

2.  Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia.

Authors:  Mojgan Kiani-Amin; Mohammadmehdi Daneshi; Parviz Ayazi; Shima Mohammadian; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

3.  Evaluation of immune system in patients with transfusion-dependent beta-thalassemia in Rasoul-e-Akram Hospital in 2021: A descriptive cross-sectional study.

Authors:  Fahime Ehsanipour; Pooya Faranoush; Mohammad Reza Foroughi-Gilvaee; Negin Sadighnia; Morteza Fallahpour; Mona Motamedi; Afsoon Zandi; Zahra Safaei; Ashkan Zandi; Mohammad Faranoush
Journal:  Health Sci Rep       Date:  2022-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.